drugset / Trial / NCT02017535
An Adaptive Treatment Strategy for Adolescent Depression-Continuation
RandomizedParallel-groupSingle-blindHealth-services research
Summary
Aim 1: Assess the feasibility and acceptability of the personalized continuation treatment strategy. Aim 2: Estimate variances of primary and secondary outcomes with the continuation treatment. Aim 3: Conduct exploratory hypothesis-generating analyses to inform further development of the personalized continuation treatment strategy to be tested in a subsequent R01 proposal.
Timeline
- Start
- 2012-06
- Primary completion
- 2018-10-01
- Completion
- 2018-10-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluoxetine | Small molecule | 20 mg | Oral |
| Subject | Fluoxetine | Small molecule | 60 mg | Oral |
Indications
No indication recorded.